|
BUB1B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.659600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.343600E-02 |
| Normal-vs-Stage2 |
2.564400E-01 |
| Normal-vs-Stage3 |
1.960450E-01 |
| Normal-vs-Stage4 |
6.399800E-02 |
| Stage1-vs-Stage2 |
3.324200E-01 |
| Stage1-vs-Stage3 |
1.059620E-01 |
| Stage1-vs-Stage4 |
8.839000E-01 |
| Stage2-vs-Stage3 |
9.370600E-01 |
| Stage2-vs-Stage4 |
3.738400E-01 |
| Stage3-vs-Stage4 |
2.410200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.978000E-02 |
| Normal-vs-AfricanAmerican |
1.532380E-01 |
| Normal-vs-Asian |
4.977900E-02 |
| Caucasian-vs-AfricanAmerican |
7.413600E-01 |
| Caucasian-vs-Asian |
6.471000E-01 |
| AfricanAmerican-vs-Asian |
9.574200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.199900E-02 |
| Normal-vs-Female |
9.330400E-02 |
| Male-vs-Female |
2.733600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.843880E-02 |
| Normal-vs-Age(41-60Yrs) |
2.632800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.188420E-01 |
| Normal-vs-Age(81-100Yrs) |
2.417200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.044300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.683170E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.856200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.557600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.792000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.627400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.961000E-01 |
| Classical-VS-Follicular |
5.113600E-01 |
| Classical-VS-Other |
2.358600E-01 |
| Classical-VS-Normal |
3.193600E-02 |
| Tall-VS-Follicular |
8.800200E-01 |
| Tall-VS-Other |
4.303000E-01 |
| Tall-VS-Normal |
1.167840E-01 |
| Follicular-VS-Other |
6.578400E-01 |
| Follicular-VS-Normal |
1.283790E-01 |
| Other-VS-Normal |
6.201000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.993800E-02 |
| Normal-vs-N1 |
2.043000E-01 |
| N0-vs-N1 |
4.922800E-01 |
|
|
